Adapted Diving Mask (ADM) device as respiratory support with oxygen output during COVID-19 pandemic
Loading...
Official URL
Full text at PDC
Publication date
2021
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Citation
Bibiano-Guillen, C., Arias-Arcos, B., Collado-Escudero, C., Mir-Montero, M., Corella-Montoya, F., Torres-Macho, J., Buendía-Garcia, M. J., & Larrainzar-Garijo, R. (2021). Adapted Diving Mask (Adm) device as respiratory support with oxygen output during COVID-19 pandemic. The American Journal of Emergency Medicine, 39, 42-47. https://doi.org/10.1016/j.ajem.2020.10.043
Abstract
At the end of 2019, several cases of pneumonia were identified in
Wuhan (Hubei, China) [1], caused by a new Orthocoronavirinae, commonly
known as coronavirus, fromthe Coronaviridae family. In January
2020, there was a public health emergency declaration [2] and, as of
March 2020, a pandemic [3,4]. At present, more than 2 million cases
have been confirmed globally (2.160.2017 April 18th) [5-9].
In Spain, the first spots of epidemiological interestwere identified in
Madrid. Some of them were registered in the sanitary region where
both Hospital Universitario Infanta Leonor and Virgen de la Torre Hospitals
belong. The first PCR-positive patient was detected on March 4th. After
two weeks, on 18th March, the number of positive cases increased to
302, and 41 patients died. By 1st April, one month after the outbreak,
the total number of caseswas 1714. These data confirmed the explosive
progression of the pandemic and the high mortality of patients who
were hospitalized and made it necessary to implement several and different
therapeutic measures to try and revert the catastrophic progression
of this infection.
The most extended therapeutic approach for COVID-19 is based on
two main strategies [10-13]: pharmacological treatment directed toward
several physiological targets (viremia, immunological reactions,
prothrombotic reactions) and hemodynamic and respiratory support
with positive end-expiratory pressure (PEEP) in addition to mechanical
ventilation. This is vitally necessary until pharmacological treatment or
patient immune responses become effective.
China and Italy have already described that acute respiratory distress
syndrome.
(ARDS) is the most common manifestation in the clinical course of
COVID-19 pneumonia [11-14]; however, this syndrome has a different
progression than other respiratory diseases. The first-choice treatment
for ARDS is mechanical ventilation (MV) with the use of orotracheal intubation
(OTI). The ARDSmortality rate is over 50%, and the delay in this
procedure is related to an even worse prognosis [15,16].
The main limiting factors that healthcare systems must face when
handling these critical patients are the limited access to ventilators
and ICU resources and the fact that they are already overwhelmed by
massive hospitalization due to respiratory distress and OTI needs
[17,18]. This is why current lines of work are focused on developing respiratory
support alternatives that will gain time or allow the maintenance
of an acceptable respiratory status until patients can access the
ICU [19,20]. In the absence of approvedmechanical devices, such as continuous
positive airway pressure (CPAP), positive end-expiratory pressure
(PEEP) devices are being used [14,16,21]. In this paper, we
describe our experience with the adaptation of diving masks (Fig. 1)
and predesigned and 3D-printed pieces (Annex) that